Market Research Report
NEEDLE-FREE IV CONNECTORS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2017-2025
|Published by||Coherent Market Insights||Product code||554058|
Delivery time: 1-2 business days
|NEEDLE-FREE IV CONNECTORS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2017-2025|
|Published: September 8, 2017||Content info:||
Needle-free IV connectors reduce the risk of microbial and bacterial contamination during intravenous injections, and thus, have received FDA approval. Needle free IV connectors are used to prevent contamination, a common occurrence with conventional metal needles. Needleless connectors are an integral part of the IV delivery system, as it provides maximum safety to the patient as well the healthcare professional. There are several needle free connectors present in the market that reduces the fluid displacement as well possess zero fluid reflux while infusing the liquid. The healthcare sector in developed and emerging economies are inclining towards adopting infusion therapy which are completely needle free, thereby trying to ensure maximum safety and quality to the patients. The use of needle free connectors are highly effective in reducing the risks involved in the bloodstream infections.
As per stats released by the WHO in 2014, around 80,000 catheter-related blood stream infections (CRBSI) were reported in the U.S. with the use of central venous catheters thereby leading to increase in the overall cost that the patient bears in terms of pharmacy charges, lab tests and duration in ICU. Needle free connectors are the best way to substantially reduce the bloodstream infection which in turn will reduce the additional expenses from which the patients are suffering.
The global needle free IV connectors market can be segmented on the basis of fluid displacement mechanism, commercial availability, end user and geographical regions.
Based on the type of fluid displacement mechanism, the global market is segmented into-
The global needle free IV connectors market is mainly dominated by positive fluid displacement connectors due to its low cost and better efficiency in reducing bloodstream infections. The positive fluid displacement connectors was attributed to account largest market share of around 34% in 2013.
On the basis of commercial availability, the global market is segmented into -
Based on the end user, the global needle free IV connectors market is segmented into-
On the basis of regional segmentation, the global needle free IV connectors market can be segmented into North America, Europe, Latin America, Asia Pacific, Middle East and Africa. North America leads the needle free IV connectors industry due to rise in the geriatric population. For instance, the National Institute of Health (NIH) suggests that 8.5% of the worldwide population are aged 65 years and above leading to the fact that this population is more prone towards incidence of chronic diseases. Apart from this, several other factors driving the growth of the market includes government investments and funding to improve healthcare infrastructure, awareness in people and healthcare practitioners. Asia pacific is expected to show striking growth over the forecast period due to growth in prevalence of chronic diseases and improvement in the healthcare facilities.
The bacterial and microbial bloodstream infection caused due to the use conventional needle stick devices is the major factor responsible for boost of the needle free IV connectors market. The needle free devices not only reduce the risk of these infections, but also provides convenience to the medical and nursing personnel to administer to draw fluids into and out of the bloodstream. The low cost of positive fluid displacement connectors is another important reason responsible to boost the needle free IV connectors market. However, increase in the rate of catheter related blood stream infections (CRBSI) could hinder the growth of needle free IV connector market.
Key players of the needle free IV connectors market includes Hospira, Baxter healthcare corporation, CareFusion Corporation, ICU Medical, Becton, Dickinson and Company, B. Braun Medical Inc., RyMed Technologies, Vygon SA and Nexus Medical LLC. In 2016, Hospira announced a CE mark approval for the launch of its new IV connector.
Middle East Introduction Market Share Analysis, By Country, 2016 and 2025 (%) Country Trends Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
*Key pointers provided are also applicable to other companies covered in the scope of the report.
Note: The table of content is subject for change/refinement based on the availability of information through secondary and primary sources during the course of study.